Genprex (GNPX) Insider Trading & Ownership $0.24 -0.02 (-6.07%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$0.25 +0.01 (+3.33%) As of 04/17/2025 05:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Genprex (NASDAQ:GNPX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage8.47%Number OfInsiders Buying(Last 3 Years)2Amount OfInsider Buying(Last 3 Years)$41,350.00Number OfInsiders Selling(Last 3 Years)0 Get GNPX Insider Trade Alerts Want to know when executives and insiders are buying or selling Genprex stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address GNPX Insider Buying and Selling by Quarter Genprex Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/21/2023Catherine M VaczyEVPBuy500$42.80$21,400.00 4/21/2023John Rodney VarnerCEOBuy475$42.00$19,950.00 (Data available from 1/1/2013 forward) GNPX Insider Trading Activity - Frequently Asked Questions Who is on Genprex's Insider Roster? The list of insiders at Genprex includes Catherine M Vaczy, and John Rodney Varner. Learn more on insiders at GNPX. What percentage of Genprex stock is owned by insiders? 8.47% of Genprex stock is owned by insiders. Learn more on GNPX's insider holdings. Which Genprex insiders have been buying company stock? The following insiders have purchased GNPX shares in the last 24 months: Catherine M Vaczy ($21,400.00), and John Rodney Varner ($19,950.00). How much insider buying is happening at Genprex? Insiders have purchased a total of 975 GNPX shares in the last 24 months for a total of $41,350.00 bought. Genprex Key ExecutivesDr. Mark S. Berger M.D. (Age 69)Chief Medical Officer Compensation: $528.16kMr. David M. SchlossSenior Vice President of Human ResourcesMr. Thomas C. Gallagher Esq.Senior Vice President of Intellectual Property & LicensingDr. Suzanne Thornton-JonesSenior Vice President of Regulatory Affairs & Quality More Insider Trading Tools from MarketBeat Related Companies Orgenesis Insider Ownership TherapeuticsMD Insider Ownership HCW Biologics Insider Ownership Athira Pharma Insider Ownership Minerva Neurosciences Insider Ownership Flora Growth Insider Ownership BioCardia Insider Ownership Biomerica Insider Ownership GeoVax Labs Insider Ownership Aprea Therapeutics Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Beware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or HoldJoby Aviation: Operational Momentum vs. Market SentimentMicroStrategy Sees Insider Buy-Sell Action in Q1 This page (NASDAQ:GNPX) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored100-year-old investment secret predicts what?!A 100-year-old indicator has quietly predicted nearly every major market meltdown — including the Dot-Com Bust...Weiss Ratings | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | Sponsored2025 could be "worse than the dot-com bust", says man who predicted 2008 banking crisisWhat's coming next to the U.S. market could be worse than anything we've ever seen before – worse than the dot...Stansberry Research | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genprex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Genprex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GNPX Stock Free GNPX Stock Alerts